M. Detorio

发表

Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.

J. Buolamwini, T. Sanchez, N. Neamati, 2013, Bioorganic & medicinal chemistry letters.

Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosides.

R. Schinazi, E. Theodorakis, S. Fernández, 2012, Bioorganic & medicinal chemistry.

Synthesis and anti-HIV-1 screening of novel N′-(1-(aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(1H)-yl)acetohydrazides

R. Schinazi, Sana Aslam, Matloob Ahmad, 2014, Archives of pharmacal research.

Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.

B. Lefkove, R. Schinazi, J. Arbiser, 2007, Bioorganic & Medicinal Chemistry Letters.

Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase

Richard A. Stanton, J. Nettles, R. Schinazi, 2011, Antimicrobial Agents and Chemotherapy.

β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms.

R. Schinazi, Sijia Tao, M. Ehteshami, 2015, Journal of medicinal chemistry.

The Base Component of 3′-Azido-2′,3′-Dideoxynucleosides Influences Resistance Mutations Selected in HIV-1 Reverse Transcriptase

J. Mellors, R. Schinazi, N. Sluis-Cremer, 2011, Antimicrobial Agents and Chemotherapy.

Anti-Human Immunodeficiency Virus Activity, Cross-Resistance, Cytotoxicity, and Intracellular Pharmacology of the 3′-Azido-2′,3′-Dideoxypurine Nucleosides

J. Mellors, R. Schinazi, N. Sluis-Cremer, 2009, Antimicrobial Agents and Chemotherapy.

Chemoenzymatic syntheses and anti-HIV-1 activity of glucose-nucleoside conjugates as prodrugs.

R. Schinazi, S. Fernández, V. Gotor, 2010, Bioconjugate chemistry.

Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro

R. Schinazi, V. Planelles, A. Bosque, 2014, Antimicrobial Agents and Chemotherapy.

Performance evaluation of the Asante Rapid Recency Assay for verification of HIV diagnosis and detection of recent HIV-1 infections: Implications for epidemic control

Ernest L. Yufenyuy, M. Detorio, B. Parekh, 2022, PLOS global public health.

Monitoring Medication Adherence by Unannounced Pill Counts Conducted by Telephone: Reliability and Criterion-Related Validity

A. Caliendo, R. Schinazi, S. Kalichman, 2008, HIV clinical trials.

Differential Maintenance of the M184V Substitution in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Various Nucleoside Antiretroviral Agents in Tissue Culture

M. Wainberg, B. Brenner, D. Moisi, 2004, Antimicrobial Agents and Chemotherapy.

Substrate mimicry: HIV-1 reverse transcriptase recognizes 6-modified-3′-azido-2′,3′-dideoxyguanosine-5′-triphosphates as adenosine analogs

Richard A. Stanton, J. Nettles, J. Mellors, 2011, Nucleic acids research.

Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.

R. Schinazi, L. Bassit, F. Amblard, 2014, Bioorganic & medicinal chemistry.

Adenosine Dioxolane Nucleoside Phosphoramidates as Antiviral Agents for Human Immunodeficiency and Hepatitis B Viruses.

R. Schinazi, Sijia Tao, L. Bassit, 2013, ACS medicinal chemistry letters.

The Base Component of 3 (cid:1) -Azido-2 (cid:1) ,3 (cid:1) -Dideoxynucleosides Inﬂuences Resistance Mutations Selected in HIV-1 Reverse Transcriptase (cid:1)

J. Mellors, R. Schinazi, N. Sluis-Cremer, 2011 .

Effects of a Single Amino Acid Substitution within thep2 Region of Human Immunodeficiency Virus Type 1 on Packagingof Spliced ViralRNA

M. Wainberg, C. Liang, A. Roldán, 2003, Journal of Virology.

Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors.

R. Schinazi, F. Amblard, Long-hu Zhou, 2013, Bioorganic & medicinal chemistry letters.

Packaging of Spliced Viral RNA Immunodeficiency Virus Type 1 on within the p 2 Region of Human Effects of a Single Amino Acid Substitution

M. Wainberg, C. Liang, A. Roldán, 2003 .

Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages

R. Schinazi, S. Hurwitz, L. Bassit, 2012, Antimicrobial Agents and Chemotherapy.

The M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates

M. Wainberg, B. Brenner, D. Moisi, 2003, Antimicrobial Agents and Chemotherapy.

Synthesis and antiviral evaluation of 2′,3′-dideoxy-2′,3′-difluoro-D-arabinofuranosyl 2,6-disubstituted purine nucleosides

R. Schinazi, F. Amblard, M. Detorio, 2015, Heterocyclic communications.

Synthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agents.

R. Schinazi, Long-hu Zhou, M. Detorio, 2011, Bioorganic & medicinal chemistry letters.

Anti-HIV activity of new pyrazolobenzothiazine 5,5-dioxide-based acetohydrazides

R. Schinazi, Sana Aslam, Matloob Ahmad, 2015, Medicinal Chemistry Research.

Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives

Syed Umar Farooq Rizvi, R. Schinazi, M. Detorio, 2011, Medicinal Chemistry Research.

Synthesis, molecular docking and antiviral screening of novel N′-substitutedbenzylidene-2-(4-methyl-5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-1(4H)-yl)acetohydrazides

R. Schinazi, J. Gardiner, M. Athar, 2013, Medicinal Chemistry Research.

Synthesis of novel pyrazolobenzothiazine 5,5-dioxide derivatives as potent anti-HIV-1 agents

Mujahid Hussain Bukhari, R. Schinazi, Sana Aslam, 2013, Medicinal Chemistry Research.

Synthesis and Antiviral Activity of Purine 2′,3′-Dideoxy-2′,3′-Difluoro-D-Arabinofuranosyl Nucleosides

R. Schinazi, M. Detorio, Tony Whitaker, 2009, Nucleosides, nucleotides & nucleic acids.

Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.

B. Lefkove, R. Schinazi, J. Arbiser, 2007, Bioorganic & medicinal chemistry letters.

Retinazone Inhibits Certain Blood-Borne Human Viruses Including Ebola Virus Zaire

R. Schinazi, D. K. Nevin, D. Lloyd, 2014, Antiviral chemistry & chemotherapy.

Synthesis , evaluation of anti-HIV-1 and anti-HCV activity of novel 2 0 , 3 0-dideoxy-2 0 , 2 0-difluoro-4 0-azanucleosides

R. Schinazi, E. Theodorakis, S. Fernández, 2012 .

Anti-HIV-1 screening of (2E)-3-(2-chloro-6-methyl/methoxyquinolin-3-yl)-1-(aryl)prop-2-en-1-ones

Mujahid Hussain Bukhari, Syed Umar Farooq Rizvi, R. Schinazi, 2013, Medicinal Chemistry Research.

Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides.

J. Nettles, J. Mellors, R. Schinazi, 2011, European journal of medicinal chemistry.

Synthesis and Biological Evaluation of 4'-C,3'-O-Propylene-Linked Bicyclic Nucleosides.

R. Schinazi, C. Len, Virginie Silvestre, 2011, European journal of organic chemistry.

Pre-steady-state Kinetic Studies Establish Entecavir 5′-Triphosphate as a Substrate for HIV-1 Reverse Transcriptase*

Robert A. Domaoal, Christopher M. Bailey, R. Siliciano, 2008, Journal of Biological Chemistry.

Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus.

Steven J Coats, J. Mellors, R. Schinazi, 2010, Bioorganic & Medicinal Chemistry Letters.

Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphates.

R. Schinazi, Megan H. Powdrill, M. Götte, 2011, Bioorganic & medicinal chemistry letters.

Randomized Clinical Trial of HIV Treatment Adherence Counseling Interventions for People Living With HIV and Limited Health Literacy

A. Caliendo, R. Schinazi, S. Kalichman, 2013, Journal of acquired immune deficiency syndromes.

Synthesis, antiviral activity, and stability of nucleoside analogs containing tricyclic bases.

R. Schinazi, Emilie Fromentin, F. Amblard, 2009, European journal of medicinal chemistry.

Long-Term Exposure to AZT, but not d4T, Increases Endothelial Cell Oxidative Stress and Mitochondrial Dysfunction

Dean P. Jones, R. Schinazi, S. Dikalov, 2009, Cardiovascular Toxicology.

Sexual HIV Transmission and Antiretroviral Therapy: A Prospective Cohort Study of Behavioral Risk Factors Among Men and Women Living with HIV/AIDS

A. Caliendo, R. Schinazi, S. Kalichman, 2011, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Bluma G. Brenner, M. Wainberg, B. Brenner, 2002, Journal of Virology.

Antiviral Agents Derived from Novel 1-adamantyl Singlet Nitrenes

R. Schinazi, D. Barnard, A. Schönleber, 2012, Antiviral chemistry & chemotherapy.

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

M. Wainberg, J. Schapiro, B. Brenner, 2003, AIDS.

A Comprehensive Approach to Assuring Quality of Laboratory Testing in HIV Surveys: Lessons Learned From the Population-Based HIV Impact Assessment Project

Ernest L. Yufenyuy, Robert A. Domaoal, K. Sleeman, 2021, Journal of acquired immune deficiency syndromes.

Universal Profiling of HIV-1 Pol for Genotypic Study and Resistance Analysis Across Subtypes

R. Schinazi, M. Detorio, Ting Nie, 2011, Antiviral therapy.

Performance of HIV rapid testing algorithm in Nigeria: Findings from a household-based Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS)

I. Adewole, A. Abimiku, M. Swaminathan, 2022, PLOS global public health.

Molecular docking and antiviral activity of N-substituted benzyl/phenyl-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl)acetamides.

Syed Umar Farooq Rizvi, R. Schinazi, J. Gardiner, 2015, Bioorganic & medicinal chemistry letters.

Synthesis, molecular docking and antiviral screening of novel N′-substitutedbenzylidene-2-(4-methyl-5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-1(4H)-yl)acetohydrazides

R. Schinazi, J. Gardiner, M. Athar, 2014, Medicinal Chemistry Research.

Synthesis of novel pyrazolobenzothiazine 5,5-dioxide derivatives as potent anti-HIV-1 agents

Mujahid Hussain Bukhari, R. Schinazi, Sana Aslam, 2014, Medicinal Chemistry Research.

The M184V Mutation in Reverse Transcriptase Can Delay Reversion of Attenuated Variants of Simian Immunodeficiency Virus

M. Wainberg, J. Whitney, Maureen Oliveira, 2002, Journal of Virology.

The M 184 V Mutation in Reverse Transcriptase Can Delay Reversion of Attenuated Variants of Simian Immunodeficiency Virus

M. Wainberg, J. Whitney, Maureen Oliveira, 2002 .

Partial Restoration of Replication of Simian Immunodeficiency Virus by Point Mutations in either the Dimerization Initiation Site (DIS) or Gag Region after Deletion Mutagenesis within the DIS

M. Wainberg, C. Liang, J. Whitney, 2001, Journal of Virology.

Nucleotide and Amino Acid Polymorphisms at Drug Resistance Sites in Non-B-Subtype Variants of Human Immunodeficiency Virus Type 1

M. Wainberg, B. Brenner, D. Moisi, 2004, Antimicrobial Agents and Chemotherapy.

Food Insufficiency and Medication Adherence Among People Living with HIV/AIDS in Urban and Peri-Urban Settings

Jennifer A. Pellowski, A. Caliendo, R. Schinazi, 2011, Prevention Science.

Use of dietary supplements among people living with HIV/AIDS is associated with vulnerability to medical misinformation on the internet

A. Caliendo, R. Schinazi, S. Kalichman, 2012, AIDS Research and Therapy.

Interleukin-16 does not suppress HIV-1 replication in naturally infected peripheral blood mononuclear cells.

S. Owatari, H. Tsuchie, K. Yoshizaki, 1997, AIDS.

HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates

Ernest L. Yufenyuy, Y. Mengistu, G. Musuka, 2021, Journal of acquired immune deficiency syndromes.

Difference in susceptibility to CC chemokines among HIV 1 isolates

H. Tsuchie, T. Kurimura, K. Taniguchi, 1998, International journal of STD & AIDS.

Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives

Syed Umar Farooq Rizvi, R. Schinazi, M. Detorio, 2012, Medicinal Chemistry Research.

Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance.

M. Wainberg, B. Brenner, D. Moisi, 2002, Antiviral research.

Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana.

M. Wainberg, B. Brenner, D. Moisi, 2002, Antiviral therapy.

Construction and In Vitro Properties of a Series of Attenuated Simian Immunodeficiency Viruses with All Accessory Genes Deleted

M. Wainberg, J. Whitney, Y. Guan, 2001, Journal of Virology.

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

M. Wainberg, B. Brenner, D. Moisi, 2002, Antimicrobial Agents and Chemotherapy.

Monthly Unannounced Pill Counts for Monitoring HIV Treatment Adherence: Tests for Self-Monitoring and Reactivity Effects

A. Caliendo, R. Schinazi, S. Kalichman, 2010, HIV clinical trials.

Anti-HIV activity of new pyrazolobenzothiazine 5,5-dioxide-based acetohydrazides

R. Schinazi, Sana Aslam, Matloob Ahmad, 2015, Medicinal Chemistry Research.

Suppression of HIV replication in vitro by CD8+ T-cells from HIV-infected and HIV-seronegative individuals

J. Dwyer, H. Tsuchie, A. Trickett, 1997, International journal of STD & AIDS.